For PPIs, the differences between the PIP and appropriate alternative did not reach statistical significance due to uncertainty in the risk of adverse events attributable to using maximal doses relative to maintenance doses ( figure 1 ).
← all excerpts
Economic impact of potentially inappropriate prescribing and related adverse events in older people: a cost-utility analysis using Markov models.
1
—
—